tradingkey.logo

Nuwellis Inc

NUWE
2.690USD
-0.078-2.83%
Close 11/04, 16:00ETQuotes delayed by 15 min
33.76KMarket Cap
LossP/E TTM

Nuwellis Inc

2.690
-0.078-2.83%

More Details of Nuwellis Inc Company

Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

Nuwellis Inc Info

Ticker SymbolNUWE
Company nameNuwellis Inc
IPO dateFeb 16, 2012
CEOErb (John L)
Number of employees38
Security typeOrdinary Share
Fiscal year-endFeb 16
Address12988 Valley View Rd
CityEDEN PRAIRIE
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code55344
Phone19523454200
Websitehttps://www.nuwellis.com/
Ticker SymbolNUWE
IPO dateFeb 16, 2012
CEOErb (John L)

Company Executives of Nuwellis Inc

Name
Name/Position
Position
Shareholding
Change
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
803.00
--
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
3.00
--
Mr. David Alan (Dave) Mcdonald
Mr. David Alan (Dave) Mcdonald
Independent Director
Independent Director
3.00
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
803.00
--
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
3.00
--
Mr. David Alan (Dave) Mcdonald
Mr. David Alan (Dave) Mcdonald
Independent Director
Independent Director
3.00
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--

Revenue Breakdown

No Data
No Data
By Business
By Region
No Data

Shareholding Stats

Updated: Sat, Aug 16
Updated: Sat, Aug 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Sabby Management, LLC
0.67%
Bigger Capital Funds, LP
0.63%
UBS Financial Services, Inc.
0.36%
Geode Capital Management, L.L.C.
0.17%
XTX Markets LLC
0.08%
Other
98.09%
Shareholders
Shareholders
Proportion
Sabby Management, LLC
0.67%
Bigger Capital Funds, LP
0.63%
UBS Financial Services, Inc.
0.36%
Geode Capital Management, L.L.C.
0.17%
XTX Markets LLC
0.08%
Other
98.09%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
0.84%
Hedge Fund
0.72%
Investment Advisor
0.36%
Venture Capital
0.08%
Research Firm
0.02%
Individual Investor
0.02%
Other
97.96%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
18
13.51K
2.03%
+10.13K
2025Q2
27
9.97K
1.46%
+7.11K
2025Q1
26
140.31K
3.15%
+23.64K
2024Q4
25
113.78K
2.60%
+73.44K
2024Q3
29
65.32K
2.68%
+45.76K
2024Q2
28
42.02K
3.15%
+30.15K
2024Q1
26
9.25K
4.91%
+1.97K
2023Q4
26
6.22K
6.75%
+3.61K
2023Q3
35
1.28K
4.82%
-1.76K
2023Q2
36
1.31K
5.00%
-797.00
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Sabby Management, LLC
3.52K
0.67%
+3.52K
--
Jun 30, 2025
Bigger Capital Funds, LP
5.69K
0.63%
+5.69K
--
Jun 09, 2025
UBS Financial Services, Inc.
1.88K
0.36%
+1.78K
+1797.98%
Jun 30, 2025
Geode Capital Management, L.L.C.
898.00
0.17%
+82.00
+10.05%
Jun 30, 2025
XTX Markets LLC
758.00
0.08%
+336.00
+79.62%
Jun 30, 2025
Two Sigma Investments, LP
415.00
0.08%
-23.00
-5.25%
Jun 30, 2025
Erb (John L)
803.00
0.02%
+803.00
--
Jun 10, 2025
Tower Research Capital LLC
132.00
0.01%
-14.00
-9.59%
Jun 30, 2025
Morgan Stanley & Co. LLC
126.00
0.01%
+126.00
--
Jun 30, 2025
SBI Securities Co., Ltd.
61.00
0.01%
+52.00
+577.78%
Jun 30, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Date
Type
Ratio
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Oct 17, 2020
Merger
30→1
Oct 17, 2020
Merger
30→1
View more
KeyAI